- Atypical antipsychotics were prescribed in 87% of first visits, reflecting preference for better tolerability and lower extrapyramidal side effects.
- Combination therapies and polypharmacy were common, with significant dose variability in risperidone, olanzapine, aripiprazole, clonazepam and lorazepam (p<0.001).
- Prospective monitoring using WHO prescribing indicators yielded structured evidence to inform optimisation of rational prescribing in schizophrenia management.
Bioinformation. 2026 Jun 30;22(6):3568-3571. doi: 10.6026/973206300223568. eCollection 2026.
ABSTRACT
Inadequate and poorly documented data on psychotropic drug utilization in schizophrenia in India necessitates systematic evaluation of prescribing patterns and associated adverse drug reactions. This prospective observational study assessed drug utilization, prescription rationality and adverse drug reactions among schizophrenia patients attending a tertiary care psychiatric outpatient department using WHO prescribing indicators. A total of 112 prescriptions comprising 285 drugs were analyzed, with atypical antipsychotics prescribed in 87% of first-visit cases, while combination therapies and polypharmacy were frequently observed. Significant dose variations were noted in commonly used antipsychotics such as risperidone, olanzapine and aripiprazole, as well as benzodiazepines like clonazepam and lorazepam (p<0.001). Atypical antipsychotics predominated due to better tolerability and lower extrapyramidal side effects, highlighting evolving prescribing trends. Thus, structured evidence on drug utilization patterns and variability in dosing, help in optimizing rational prescribing practices in schizophrenia management.
PMID:42701729 | PMC:PMC13545880 | DOI:10.6026/973206300223568
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

